ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Approximately 0.5%-1% of the general population has been estimated to be heterozygous for a germline mutation in the ATM gene. Mutations in the ATM gene are responsible for the autosomal recessive disorder ataxia-telangiectasia (A-T) (MIM 208900). The finding that ATM-heterozygotes have an increased relative risk for breast cancer was supported by some studies but not confirmed by others. In view of this discrepancy, we examined the frequency of ATM germline mutations in a selected group of Dutch patients with breast cancer. We have analyzed ATM germline mutations in normal blood lymphocytes, using the protein-truncation test followed by genomic-sequence analysis. A high percentage of ATM germline mutations was demonstrated among patients with sporadic breast cancer. The 82 patients included in this study had developed breast cancer at age <45 and had survived >/=5 years (mean 15 years), and in 33 (40%) of the patients a contralateral breast tumor had been diagnosed. Among these patients we identified seven (8.5%) ATM germline mutations, of which five are distinct. One splice-site mutation (IVS10-6T-->G) was detected three times in our series. Four heterozygous carriers were patients with bilateral breast cancer. Our results indicate that the mutations identified in this study are "A-T disease-causing" mutations that might be associated with an increased risk of breast cancer in heterozygotes. We conclude that ATM heterozygotes have an approximately ninefold-increased risk of developing a type of breast cancer characterized by frequent bilateral occurrence, early age at onset, and long-term survival. The specific characteristics of our population of patients may explain why such a high frequency was not found in other series.

[1]  M. Beckmann,et al.  Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study , 1999, Genes, chromosomes & cancer.

[2]  A. Aurias,et al.  Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families , 1999, British Journal of Cancer.

[3]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[4]  H. Inskip,et al.  Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia , 1999, British Journal of Cancer.

[5]  T. Dörk,et al.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.

[6]  A. Lindblom,et al.  The role of ataxia-telangiectasia heterozygotes in familial breast cancer. , 1998, Cancer research.

[7]  Y. Shiloh,et al.  Genotype-phenotype relationships in ataxia-telangiectasia and variants. , 1998, American journal of human genetics.

[8]  A. Broeks,et al.  ATM germline mutations in classical ataxia‐telangiectasia patients in the Dutch population , 1998, Human mutation.

[9]  Y. Shiloh,et al.  Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. , 1997, Genome research.

[10]  A. Børresen-Dale,et al.  Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM , 1997, Genes, chromosomes & cancer.

[11]  K. Isselbacher,et al.  Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.

[12]  Y. Shiloh,et al.  The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.

[13]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[14]  Y. Shiloh,et al.  Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. , 1996, Current opinion in immunology.

[15]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[16]  R. Cowan,et al.  A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. , 1995, International journal of radiation biology.

[17]  Y. Shiloh Ataxia-Telangiectasia: Closer to Unraveling the Mystery , 1995, European journal of human genetics : EJHG.

[18]  D. Easton Cancer risks in A-T heterozygotes. , 1994, International journal of radiation biology.

[19]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[20]  H. Vinters,et al.  Ataxia‐Telangiectasia: An Interdisciplinary Approach to Pathogenesis , 1991, Medicine.

[21]  G. Bruyn,et al.  Hereditary neuropathies and spinocerebellar atrophies , 1991 .

[22]  M. Swift,et al.  Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.

[23]  P. Smith,et al.  Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. , 1979, Cancer research.